Search Results - "Díaz Molina, B"
-
1
The Relationship of Anti‐MICA Antibodies and MICA Expression with Heart Allograft Rejection
Published in American journal of transplantation (01-07-2007)“…The role of MICA antibodies in acute heart allograft rejection was examined utilizing 190 pre‐ and post‐transplant serum samples from 44 patients collected…”
Get full text
Journal Article -
2
Effect of CYP3A5, CYP3A4, and ABCB1 Genotypes as Determinants of Tacrolimus Dose and Clinical Outcomes After Heart Transplantation
Published in Transplantation proceedings (01-11-2012)“…Abstract Background Tacrolimus (Tac) is mainly metabolized by cytochrome P450 3A isoenzymes. In a cohort of heart transplant recipients, we investigated the…”
Get full text
Journal Article Conference Proceeding -
3
Quality of Life According to Urgency Status in De Novo Heart Transplant Recipients
Published in Transplantation proceedings (01-11-2016)“…Abstract Introduction Elective heart transplantation (HTX) aims to improve physical ability, increase survival, and improve health-related quality of life…”
Get full text
Journal Article -
4
Effect of Early Conversion to Everolimus Together With Prophylaxis With Valganciclovir in the Prevention of Cytomegalovirus Infection in Heart Transplant Recipients
Published in Transplantation proceedings (2015)“…Abstract Introduction Viral infections, especially cytomegalovirus (CMV), are a leading cause of early death and morbidity after heart transplantation. Several…”
Get full text
Journal Article -
5
The falling incidence of hematologic cancer after heart transplantation
Published in Clinical transplantation (01-10-2014)“…Background A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post‐HT hematologic cancer, but…”
Get full text
Journal Article -
6
The Prognosis of Noncutaneous, Nonlymphomatous Malignancy After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumour Registry
Published in Transplantation proceedings (01-10-2010)“…Abstract Introduction Malignancy is a major complication in the management of solid organ transplant patients. Skin cancers show a better prognosis than other…”
Get full text
Journal Article Conference Proceeding -
7
Study of the Renal Function in Nonrenal Organ Transplantation
Published in Transplantation proceedings (01-11-2006)“…Kidney disease after transplantation of a nonrenal organ has been described to be the result of the nephrotoxicity from the commonly used…”
Get full text
Journal Article -
8
Malignancy After Heart Transplantation: Incidence, Prognosis and Risk Factors
Published in American journal of transplantation (01-05-2008)“…The Spanish Post‐Heart‐Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003)…”
Get full text
Journal Article -
9
-
10
436 Effect of CYP3A5, CYP3A5 and ABCB1 Genotypes in Tacrolimus Dose and Clinical Outcomes after Heart Transplantation
Published in The Journal of heart and lung transplantation (01-04-2012)Get full text
Journal Article -
11
-
12
-
13
-
14
Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure
Published in Nephrology, dialysis, transplantation (01-02-2010)“…Background. Heart failure (HF) is a major health problem in developed countries. HF is a progressive, lethal disorder, even with adequate treatment. There…”
Get full text
Journal Article -
15
Quality of Life after Urgent Heart Transplantation
Published in The Journal of heart and lung transplantation (01-04-2016)Get full text
Journal Article -
16
Incidence of Neoplasm After Heart Transplant in Patients Treated with Induction Therapy with OKT3 or Basiliximab
Published in The Journal of heart and lung transplantation (01-04-2017)Get full text
Journal Article -
17
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?
Published in International journal of cardiology (15-01-2014)“…Abstract Background In the last decade, mTOR inhibitors (mTOR-is) have become the cornerstone of the calcineurin inhibitor (CNI)-reduced/free regimens aimed to…”
Get full text
Journal Article -
18
-
19
-
20